Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
37.65
+0.40 (1.07%)
Jul 30, 2025, 9:45 AM HKT

Hansoh Pharmaceutical Group Company Company Description

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases.

Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist.

The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.

Hansoh Pharmaceutical Group Company Limited
CountryCayman Islands
Founded1995
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees8,989
CEOHuijuan Zhong

Contact Details

Address:
287 Xiangke Road
Shanghai, 201210
China
Phone86 40 0828 5227
Websitehspharm.com

Stock Details

Ticker Symbol3692
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberKYG549581067
SIC Code2834

Key Executives

NamePosition
Huijuan ZhongChairlady, Chief Executive Officer and President
Dr. Aifeng LyuExecutive Director
Yuan SunExecutive Director
Min HuVice President and Chief Financial Officer
Dr. Shan JiangChief Technology Officer
Dr. Chih-Hung LeeChief of Science Officer
Chuanhe XuSenior Vice President
Weiyong SunChief Business Officer
Dr. Xiaoqing ZhangChief Medical Officer
Shengli ZhongJoint Company Secretary and Senior Vice President